FIGURE 2-1. Relative risks and 95 percent confidence intervals for observational and clinical trial findings on hormone therapy (estrogen + progestin).

FIGURE 2-1Relative risks and 95 percent confidence intervals for observational and clinical trial findings on hormone therapy (estrogen + progestin)

SOURCE: Michels, K. B., and J. E. Manson. 2003. Postmenopausal hormone therapy: A reversal of fortune. Circulation 107:1830-1833. Reprinted with permission from Michels and Manson, Circulation, 2003.

From: 2, Cases in Point: Learning from Experience

Cover of Redesigning the Clinical Effectiveness Research Paradigm
Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches: Workshop Summary.
Institute of Medicine (US) Roundtable on Value & Science-Driven Health Care; Olsen LA, McGinnis JM, editors.
Washington (DC): National Academies Press (US); 2010.
Copyright © 2010, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.